Loading
CoreRx, a Tampa-based biopharmaceutical firm, is moving to a new facility in Largo, and plans to add 55 new high-wage jobs once the change is completed. The company's 16 current Tampa employees will remain with the company as well.
CoreRx will take advantage of Florida's Qualified Target Industry (QTI) program to help offset part of the move's costs. The firm may also borrow up to $250,000 from the state's Economic Gardening Business Loan program, a part of the U.S. Small Business Administration.
“The Tampa Bay area's medical industry is a big draw for CoreRx,” said Todd Daviau, president and CEO at CoreRx. “Being able to partner with an organization like USF allows us to compete for funding and contracts that enable us to do what we do best - produce safe, effective, and innovative drug products.”
Founded in 2006, CoreRx is a contract pharmaceutical development and manufacturing business that helps companies bring new drugs to clinical markets.
Your free article limit has been reached this month.
Subscribe now for unlimited digital access to our award-winning business news.
Join thousands of executives who rely on us for insights spanning Tampa Bay to Naples.
